Premier Research is proud to once again be a sponsor of the World Orphan Drug Congress (WODC) Europe taking place November 12-14, 2019, in Barcelona, Spain. As part of our ongoing support for this innovative conference, Jonathan Kornstein, Executive Director, Program Strategy, Rare Disease & Pediatrics, will present a session entitled "A Partnership That Lasts: Key Considerations When Working With CROs on Rare Disease Studies."
Premier Research's rare disease experience spans all aspects of clinical trials and drug development, encompassing more than 190 rare disease studies across multiple indications in the past five years. Our deep connections with advocacy groups help us locate hard-to-find patients, and our long experience has taught us it's important to treat them like people, not subjects.
Drawing on our expertise, sponsors are better positioned to get their products into clinical development - and ultimately to the patients who need them. If you are attending WODC Europe this year, please come by booth #8 and meet our clinical research professionals.
SOURCE: Premier Research